Best deals to access real time data! |
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Arbutus Biopharma Corporation | ABUS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.09 | 4.05% | 2.31 | 2.35 | 2.22 | 2.23 | 2.22 | 12:50:35 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 2.31 | 2.33 | 0.02 | 0.86% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 620 | 146,289 | $ 2.30 | $ 336,650 | 723,639 | 0.81 - 4.78 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:50:35 | 10 | $ 2.32 | USD |
Arbutus Biopharma Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 131.32M | 56.85M | $ -57.06M | -1.21 | - | 50.93M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | 7.00 | 10.70% |
Arbutus Biopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABUS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.64 | 2.45 | 1.56 | 1.81 | 1,221,595 | 0.67 | 40.85% |
| 1 Month | 1.41 | 2.45 | 1.3879 | 1.70 | 539,185 | 0.90 | 63.83% |
| 3 Months | 1.66 | 2.45 | 0.81 | 1.39 | 591,283 | 0.65 | 39.16% |
| 6 Months | 1.69 | 2.74 | 0.81 | 1.62 | 469,945 | 0.62 | 36.69% |
| 1 Year | 4.45 | 4.78 | 0.81 | 2.19 | 360,588 | -2.14 | -48.09% |
| 3 Years | 3.00 | 12.60 | 0.81 | 4.52 | 312,686 | -0.69 | -23.0% |
| 5 Years | 12.72 | 26.73 | 0.81 | 8.57 | 358,790 | -10.41 | -81.84% |
Arbutus Biopharma Description
| Arbutus Biopharma Corp is a pharmaceutical company. It discovers, develops and commercializes cure for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and also involved in licensing of Lipid nanoparticle technology. |
